Journal
NUTRITION RESEARCH
Volume 48, Issue -, Pages 85-92Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.nutres.2017.10.012
Keywords
Diacylglycerols; Alpha-linolenic acid; Lipid metabolism; Isotope labeling; Clinical trial
Categories
Funding
- Kao Corporation
Ask authors/readers for more resources
Fat metabolism is an important consideration in obesity. Alpha-linolenic acid-enriched diacylglycerol (ALA-DAG), which mainly occurs as ALA esterifies to 1,3-diacyl-sn-glycerol (1,3-DAG), has beneficial effects on fat metabolism and body weight compared with triacylglycerol (TAG). Moreover, compared with ALA-TAG, ALA-DAG enhances p-oxidation activity in the small intestine and liver in rodents. We hypothesized that ALA-DAG consumption may increase dietary fat oxidation compared with ALA-TAG in humans. To examine this hypothesis, we conducted a randomized double-blind cross-over trial in 17 normal and moderately obese men and women (BMI: 25.7 +/- 2.0 kg/m(2), mean +/- SD). Each participant was assigned to a 4-week intervention period with 2.5 g/day of ALA-DAG or ALA-TAG consumption, followed by a 4-week washout period between consumption of each diet. Dietary fat oxidation, assessed based on the (CO2)-C-13 recovery rate in the breath, was significantly increased by ALA-DAG consumption compared with ALA-TAG consumption (17.0 +/- 4.5% and 14.1 +/- 5.9%, respectively, P < .05). In addition, ALA-DAG consumption significantly decreased the visceral fat area compared with ALA-TAG (102.9 +/- 51.9 cm(2) and 110.9 +/- 51.7 cm(2), respectively; P < .05). These results indicate that ALA-DAG consumption may be useful for preventing obesity. (C) 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available